NSTM — Novelstem International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Novelstem International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.09	0.009	0.006	0.053	0.006
Net Total Accounts Receivable
Net Total Receivables	—	—	0.012	0	0.011
Prepaid Expenses
Total Current Assets	0.121	0.037	0.059	0.087	0.032
Long Term Investments
Long Term Notes Receivable
Total Assets	3.56	2.61	2.29	2.25	0.16
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.069	0.193	0.065	0.346	5.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.069	0.193	0.353	4.21	5.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	3.49	2.42	1.93	-1.95	-5.14
Total Liabilities & Shareholders' Equity	3.56	2.61	2.29	2.25	0.16
Total Common Shares Outstanding